Related Experiment Video
Updated: Jun 22, 2026

08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Does this patient have myasthenia gravis?
Katalin Scherer1, Richard S Bedlack, David L Simel
1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. scher012@mc.duke.edu
JAMA
|April 21, 2005
Summary
Diagnosing myasthenia gravis (MG) can be improved by specific historical details and simple tests. The peek sign, ice test, edrophonium test, and sleep test aid in diagnosing MG.
Area of Science:
- Neurology
- Clinical Diagnostics
- Medical Research
Background:
- Accurate and timely diagnosis of myasthenia gravis (MG) is crucial for patient care.
- Delays in diagnosis can lead to severe complications in this treatable autoimmune disorder.
Purpose of the Study:
- To evaluate how specific historical elements and simple diagnostic tests influence the probability of diagnosing myasthenia gravis.
- To identify key clinical indicators for improving MG diagnosis.
Main Methods:
- Systematic literature review of English-language articles from MEDLINE (1966-2005) and bibliographies.
- Inclusion of studies assessing diagnostic accuracy of symptoms, signs, and tests in patients with and without myasthenia gravis.
- Data extraction and quality assessment by two independent reviewers.
Main Results:
- The history of "speech becoming unintelligible during prolonged speaking" and the presence of the peek sign significantly increase MG likelihood.
- The ice test, edrophonium test, and sleep test provide valuable diagnostic information, with abnormal results increasing and normal results decreasing MG probability.
- Other assessed signs and symptoms, such as "food remaining in the mouth after swallowing" and quiver eye movements, did not significantly alter diagnostic probability.
Conclusions:
- Clinical history, physical examination findings (e.g., peek sign), and simple bedside tests (ice, sleep, edrophonium) are valuable for diagnosing myasthenia gravis.
- Results should be interpreted cautiously due to potential biases in study populations.
- Further research is needed to validate common diagnostic maneuvers and historical features used by experts.
Related Concept Videos
Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

